DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Vascular smooth muscle contraction	R-HSA-445355	map04270	phthalylsulfathiazole	5850	drug-path
B cell receptor signaling pathway	R-HSA-983705	map04662	fluvastatin	446155	drug-path
Calcium signaling pathway	R-HSA-381753	map04020	fluvastatin	446155	drug-path
Adipocytokine signaling pathway	R-HSA-168638	map04920	fluvastatin	446155	drug-path
Colorectal cancer	R-HSA-4791275	map05210	fluvastatin	446155	drug-path
Chronic myeloid leukemia	R-HSA-9680350	map05220	fluvastatin	446155	drug-path
Pathways in cancer	R-HSA-9824443	map05200	glibenclamide	3488	drug-path
Huntington's disease	R-HSA-1643685	0	glibenclamide	3488	drug-path
Olfactory transduction	R-HSA-9751605	map04740	glibenclamide	3488	drug-path
Primary immunodeficiency	R-HSA-5601905	map05340	glibenclamide	3488	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	glibenclamide	3488	drug-path
Parkinson's disease	R-HSA-1643685	0	glibenclamide	3488	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	glibenclamide	3488	drug-path
Calcium signaling pathway	R-HSA-381753	map04020	glibenclamide	3488	drug-path
Alzheimer's disease	R-HSA-1643685	0	albendazole	6604200	drug-path
Huntington's disease	R-HSA-1643685	0	albendazole	6604200	drug-path
Olfactory transduction	R-HSA-9751605	map04740	albendazole	6604200	drug-path
Parkinson's disease	R-HSA-1643685	0	albendazole	6604200	drug-path
Ribosome	R-HSA-5368277	map03010	albendazole	6604200	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	albendazole	6604200	drug-path